Usefulness of the whole-blood interferon-gamma release assay for diagnosis of extrapulmonary tuberculosis

被引:57
作者
Song, Kyoung-Ho [2 ]
Jeon, Jae Hyun [2 ]
Park, Wan Beom [2 ]
Kim, Sung-Han [2 ]
Park, Kyoung Un [3 ]
Kim, Nam Joong [2 ]
Oh, Myoung-don [2 ]
Kim, Hong Bin [1 ,2 ]
Choe, Kang Won [2 ]
机构
[1] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam 463707, South Korea
[2] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea
[3] Seoul Natl Univ, Coll Med, Dept Lab Med, Seoul 151, South Korea
关键词
Tuberculosis; Interferon-gamma; Diagnosis; Lymphadenitis; Spondylitis; CELL-BASED ASSAY; MYCOBACTERIUM-TUBERCULOSIS; SKIN-TEST; PULMONARY TUBERCULOSIS; ACTIVE PULMONARY; INFECTION; TESTS; LYMPHADENITIS; SENSITIVITY; ANTIGENS;
D O I
10.1016/j.diagmicrobio.2008.10.013
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The whole-blood interferon-gamma enzyme-linked immunosorbent assay (QuantiFERON-TB Gold [QFT-G]; Cellestis, Carnegie, Australia) has been studied mainly for diagnosing active pulmonary tuberculosis (TB) or latent TB. We prospectively evaluated its diagnostic usefulness in patients Suspected with extrapulmonary TB (EP-TB). Of the 100 adult patients with suspected EP-TB, 43 were classified as "confirmed" EP-TB and 5 as "probable" EP-TB. Of the 48 with EP-TB, 27 (56%) were diagnosed with TB lymphadenitis and 11 (17%) with skeletal TB. The overall sensitivity and specificity of the assay were 69% (95% confidence interval [CI95], 53-81%) and 82% (CI95, 69-91%), respectively. Among 44 patients presented with cervical lymphadenopathy, the QFT-G assay showed 86% (CI95, 64-97%) sensitivity and 87% (CI95, 66-97%) specificity, whereas in 28 with skeletal involvement, the sensitivity and specificity of the assay were 45% (CI95, 17-77%) and 81% (CI95, 54-96%), respectively. These suboptimal diagnostic performances suggest that the QFT-G assay alone is not sufficient for the diagnosis of EP-TB. (c) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:182 / 187
页数:6
相关论文
共 35 条
[1]   Reversion of the ELISPOT test after treatment in Gambian tuberculosis cases [J].
Aiken, Alexander M. ;
Hill, Philip C. ;
Fox, Annette ;
McAdam, Keith P. W. J. ;
Jackson-Sillah, Dolly ;
Lugos, Moses D. ;
Donkor, Simon A. ;
Adegbola, Richard A. ;
Brookes, Roger H. .
BMC INFECTIOUS DISEASES, 2006, 6 (1)
[2]  
[Anonymous], 2000, AM J RESP CRIT CARE, V161, pS221, DOI DOI 10.1164/AJRCCM.161.SUPPLEMENT_
[3]   ISOLATED PERIPHERAL TUBERCULOUS LYMPHADENITIS IN ADULTS - CURRENT CLINICAL AND DIAGNOSTIC ISSUES [J].
ARTENSTEIN, AW ;
KIM, JH ;
WILLIAMS, WJ ;
CHUNG, RCY .
CLINICAL INFECTIOUS DISEASES, 1995, 20 (04) :876-882
[4]   The diagnosis of tuberculosis [J].
Brodie, D ;
Schluger, NW .
CLINICS IN CHEST MEDICINE, 2005, 26 (02) :247-+
[5]   Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy [J].
Carrara, S ;
Vincenti, D ;
Petrosillo, N ;
Amicosante, M ;
Girardi, E ;
Goletti, D .
CLINICAL INFECTIOUS DISEASES, 2004, 38 (05) :754-756
[6]  
*CELL INT, 2005, QUANT TB GOLD PACK I
[7]   Detection of Mycobacterium tuberculosis complex using real-time polymerase chain reaction [J].
Chang, Ho Eun ;
Heo, Se Ran ;
Yoo, Kwang Cheol ;
Song, Sang Hoon ;
Kim, Sung-Han ;
Kim, Hong Bin ;
Park, Kyoung Un ;
Song, Junghan ;
Lee, Jae Ho ;
Park, Sung Sup ;
Kim, Eui Chong .
KOREAN JOURNAL OF LABORATORY MEDICINE, 2008, 28 (02) :103-108
[8]   Low sensitivity of a whole-blood interferon-γ release assay for detection of active tuberculosis [J].
Dewan, Puneet K. ;
Grinsdale, Jennifer ;
Kawamura, L. Masae .
CLINICAL INFECTIOUS DISEASES, 2007, 44 (01) :69-73
[9]  
Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192
[10]   Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis:: a prospective study [J].
Ferrara, G ;
Losi, M ;
D'Amico, R ;
Roversi, P ;
Piro, R ;
Meacci, M ;
Meccugni, B ;
Dori, IM ;
Andreani, A ;
Bergamini, BM ;
Mussini, C ;
Rumpianesi, F ;
Fabbri, LM ;
Richeldi, L .
LANCET, 2006, 367 (9519) :1328-1334